Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 100

1.

Disparities Among Cervical Cancer Patients Receiving Brachytherapy.

Bruce SF, Joshi TV, Chervoneva I, Yi M, Chatterjee-Paer S, Burton ER, Edelson MI, Sorosky JI, Shahin MS.

Obstet Gynecol. 2019 Sep;134(3):559-569. doi: 10.1097/AOG.0000000000003401.

PMID:
31403593
2.

Implementation of an abdominal closure bundle to reduce surgical site infection in patients on a gynecologic oncology service undergoing exploratory laparotomy.

Bruce SF, Carr DN, Burton ER, Sorosky JI, Shahin MS, Naglak MC, Edelson MI.

Gynecol Oncol. 2018 Jun;149(3):560-564. doi: 10.1016/j.ygyno.2018.03.045. Epub 2018 Mar 14.

PMID:
29548786
3.

Recognition and Therapeutic Options for Malignancy of the Cervix and Uterus.

Burton ER, Sorosky JI.

Obstet Gynecol Clin North Am. 2017 Jun;44(2):195-206. doi: 10.1016/j.ogc.2017.02.009. Review.

PMID:
28499530
4.

American College of Surgeons Clinical Congress 2016.

Sorosky JI, Burton ER, Edelson MI, Shahin MS.

Gynecol Oncol. 2017 Mar;144(3):456-458. doi: 10.1016/j.ygyno.2016.12.001. Epub 2016 Dec 8. No abstract available.

PMID:
27939983
5.

American college of surgeons clinical congress 2015.

Sorosky JI, Rivard C, Edelson MI.

Gynecol Oncol. 2015 Dec;139(3):391-3. doi: 10.1016/j.ygyno.2015.10.019. Epub 2015 Oct 27. No abstract available.

PMID:
26519104
6.

We need a new paradigm in gynecologic cancer care: SGO proposes solutions for delivery, quality and reimbursement policies.

Alvarez RD, Gray HJ, Timmins PF 3rd, Gibb RK, Edelson M, Fowler JM, Havrilesky LJ, McCauley DL, Nash JD, Rahaman J, Rash JK, Rodabaugh KJ, Powell MA, Bristow RE, Brown JV, Tewari D, Cliby WA, Anastasia P, Robinson WR 3rd, Shahin MS, Cantrell LA, Cloven NG, Gold MA, Hope JM, Muntz HG, Sorosky JI, Elkas JC, Frumovitz MM, Jewell E, Spillman MA, Naumann RW.

Gynecol Oncol. 2013 Apr;129(1):3-4. No abstract available.

PMID:
23638463
7.

Endometrial cancer.

Sorosky JI.

Obstet Gynecol. 2012 Aug;120(2 Pt 1):383-97. doi: 10.1097/AOG.0b013e3182605bf1. Review.

PMID:
22825101
8.
9.

Predictive value of serum CA-125 levels in patients with persistent or recurrent epithelial ovarian cancer or peritoneal cancer treated with bevacizumab on a Gynecologic Oncology Group phase II trial.

Randall LM, Sill MW, Burger RA, Monk BJ, Buening B, Sorosky JI.

Gynecol Oncol. 2012 Mar;124(3):563-8. doi: 10.1016/j.ygyno.2011.11.035. Epub 2011 Dec 1.

10.

Prevalence of the human papillomavirus in an inner-city indigent population with previously normal Pap tests.

Werden J, Schnatz PF, Mandavilli S, Allen G, Murphy JL, Greene JF, Egan JF, Sorosky JI.

J Low Genit Tract Dis. 2008 Oct;12(4):287-92. doi: 10.1097/LGT.0b013e31817e307b.

PMID:
18820543
11.

Placental-site trophoblastic tumor with PET scan-detected surgically treated lung metastasis.

Nieves L, Hoffman J, Allen G, Currie J, Sorosky JI.

Int J Clin Oncol. 2008 Jun;13(3):263-5. doi: 10.1007/s10147-007-0721-7. Epub 2008 Jun 14.

PMID:
18553238
12.

Endometrial cancer.

Sorosky JI.

Obstet Gynecol. 2008 Feb;111(2 Pt 1):436-47. doi: 10.1097/AOG.0b013e318162f690. Review.

PMID:
18238985
13.

Phase II trial of bevacizumab in persistent or recurrent epithelial ovarian cancer or primary peritoneal cancer: a Gynecologic Oncology Group Study.

Burger RA, Sill MW, Monk BJ, Greer BE, Sorosky JI.

J Clin Oncol. 2007 Nov 20;25(33):5165-71. Erratum in: J Clin Oncol. 2014 Nov 10;32(32):3686.

PMID:
18024863
14.

Dysplasia and malignancy in endocervical polyps.

Berzolla CE, Schnatz PF, O'Sullivan DM, Bansal R, Mandavilli S, Sorosky JI.

J Womens Health (Larchmt). 2007 Nov;16(9):1317-21.

PMID:
18001188
15.

Patient choice: comparing criteria for selecting an obstetrician-gynecologist based on image, gender, and professional attributes.

Schnatz PF, Murphy JL, O'Sullivan DM, Sorosky JI.

Am J Obstet Gynecol. 2007 Nov;197(5):548.e1-7.

PMID:
17980206
16.

A retained surgical sponge presenting as chronic pelvic pain.

Nieves L, Schnatz PF, Sahakyan M, Sorosky JI.

Conn Med. 2007 Sep;71(8):461-3.

PMID:
17902383
17.

Ototoxicity after intraperitoneal chemotherapy: a case report.

Nieves L, Currie J, Hoffman J, Sorosky JI.

Int J Gynecol Cancer. 2007 Sep-Oct;17(5):1133-5. Epub 2007 Apr 13. Review.

PMID:
17433058
18.

Asymptomatic lung carcinoma presenting with a large vulvar lesion.

Cooper BC, Buekers TE, Flynn CM, Sorosky JI, Buller RE.

J Low Genit Tract Dis. 2001 Jan;5(1):48-50.

PMID:
17043562
19.

Serial therapy-induced changes in tumor shape in cervical cancer and their impact on assessing tumor volume and treatment response.

Mayr NA, Yuh WT, Taoka T, Wang JZ, Wu DH, Montebello JF, Meeks SL, Paulino AC, Magnotta VA, Adli M, Sorosky JI, Knopp MV, Buatti JM.

AJR Am J Roentgenol. 2006 Jul;187(1):65-72.

PMID:
16794157
20.

Phase II study of oxaliplatin as second-line chemotherapy in endometrial carcinoma: a Gynecologic Oncology Group study.

Fracasso PM, Blessing JA, Molpus KL, Adler LM, Sorosky JI, Rose PG.

Gynecol Oncol. 2006 Nov;103(2):523-6. Epub 2006 May 19.

PMID:
16712905
21.

Clinical significance of atypical glandular cells on cervical cytology.

Schnatz PF, Guile M, O'Sullivan DM, Sorosky JI.

Obstet Gynecol. 2006 Mar;107(3):701-8. Review.

PMID:
16507944
22.

Menopausal symptoms in Hispanic women and the role of socioeconomic factors.

Schnatz PF, Serra J, O'Sullivan DM, Sorosky JI.

Obstet Gynecol Surv. 2006 Mar;61(3):187-93. Review.

PMID:
16490118
23.

Social support, psychological distress, and natural killer cell activity in ovarian cancer.

Lutgendorf SK, Sood AK, Anderson B, McGinn S, Maiseri H, Dao M, Sorosky JI, De Geest K, Ritchie J, Lubaroff DM.

J Clin Oncol. 2005 Oct 1;23(28):7105-13.

PMID:
16192594
24.

Malignant mixed mullerian tumor (MMMT) of the cervix.

Sharma NK, Sorosky JI, Bender D, Fletcher MS, Sood AK.

Gynecol Oncol. 2005 May;97(2):442-5. Review.

PMID:
15863143
25.

Novel modification of the vertical rectus abdominis myocutaneous flap for neovagina creation.

Sood AK, Cooper BC, Sorosky JI, Ramirez PT, Levenback C.

Obstet Gynecol. 2005 Mar;105(3):514-8.

PMID:
15738017
26.

Lack of adherence to practice guidelines for women with atypical glandular cells on cervical cytology.

Sharpless KE, Schnatz PF, Mandavilli S, Greene JF, Sorosky JI.

Obstet Gynecol. 2005 Mar;105(3):501-6. Erratum in: Obstet Gynecol. 2005 Jun;105(6):1495.

PMID:
15738015
27.

Dysplasia associated with atypical glandular cells on cervical cytology.

Sharpless KE, Schnatz PF, Mandavilli S, Greene JF, Sorosky JI.

Obstet Gynecol. 2005 Mar;105(3):494-500. Erratum in: Obstet Gynecol. 2005 Jun;105(6):1495.

PMID:
15738014
28.

Brachytherapy management of the retroverted uterus using ultrasound-guided implant applicator placement.

Mayr NA, Montebello JF, Sorosky JI, Daugherty JS, Nguyen DL, Mardirossian G, Wang JZ, Edwards SM, Li W, Yuh WT.

Brachytherapy. 2005;4(1):24-9.

PMID:
15737903
29.

Cervical cancer complicating pregnancy: two patients with three clinical objectives.

Sorosky JI.

Obstet Gynecol. 2004 Nov;104(5 Pt 2):1127-8. No abstract available.

PMID:
15516423
30.

Genomic instability is associated with lack of telomerase activation in ovarian cancer.

Landen CN, Klingelhutz A, Coffin JE, Sorosky JI, Sood AK.

Cancer Biol Ther. 2004 Dec;3(12):1250-3. Epub 2004 Dec 14.

PMID:
15477760
31.

Sequential intraperitoneal topotecan and oral etoposide chemotherapy in recurrent platinum-resistant ovarian carcinoma: results of a phase II trial.

Sood AK, Lush R, Geisler JP, Shahin MS, Sanders L, Sullivan D, Buller RE, Sorosky JI.

Clin Cancer Res. 2004 Sep 15;10(18 Pt 1):6080-5.

32.

Pseudoaneurysm of the uterine artery requiring bilateral uterine artery embolization.

Cooper BC, Hocking-Brown M, Sorosky JI, Hansen WF.

J Perinatol. 2004 Sep;24(9):560-2.

PMID:
15329736
33.
34.

Docetaxel versus paclitaxel for adjuvant treatment of ovarian cancer: case-control analysis of toxicity.

Hsu Y, Sood AK, Sorosky JI.

Am J Clin Oncol. 2004 Feb;27(1):14-8.

PMID:
14758127
35.

Operative note dictation: should it be taught routinely in residency programs?

Eichholz AC, Van Voorhis BJ, Sorosky JI, Smith BJ, Sood AK.

Obstet Gynecol. 2004 Feb;103(2):342-6.

PMID:
14754706
36.
37.

A randomized phase II evaluation of bryostatin-1 (NSC #339555) in persistent or recurrent squamous cell carcinoma of the cervix: A Gynecologic Oncology Group Study.

Armstrong DK, Blessing JA, Rader J, Sorosky JI; Gynecologic Oncology Group Study.

Invest New Drugs. 2003 Nov;21(4):453-7.

PMID:
14586213
38.

Does prone positioning reduce small bowel dose in pelvic radiation with intensity-modulated radiotherapy for gynecologic cancer?

Adli M, Mayr NA, Kaiser HS, Skwarchuk MW, Meeks SL, Mardirossian G, Paulino AC, Montebello JF, Gaston RC, Sorosky JI, Buatti JM.

Int J Radiat Oncol Biol Phys. 2003 Sep 1;57(1):230-8.

PMID:
12909238
39.

Serum CA 125 is an independent prognostic factor in cervical adenocarcinoma.

Bender DP, Sorosky JI, Buller RE, Sood AK.

Am J Obstet Gynecol. 2003 Jul;189(1):113-7.

PMID:
12861147
40.

Postoperative wound infection with Pasteurella multocida from a pet cat.

Chun ML, Buekers TE, Sood AK, Sorosky JI.

Am J Obstet Gynecol. 2003 Apr;188(4):1115-6.

PMID:
12712125
41.

Anorectal dysfunction after surgical treatment for cervical cancer.

Sood AK, Nygaard I, Shahin MS, Sorosky JI, Lutgendorf SK, Rao SS.

J Am Coll Surg. 2002 Oct;195(4):513-9.

PMID:
12375757
42.

Preoperative serum vascular endothelial growth factor levels: significance in ovarian cancer.

Cooper BC, Ritchie JM, Broghammer CL, Coffin J, Sorosky JI, Buller RE, Hendrix MJ, Sood AK.

Clin Cancer Res. 2002 Oct;8(10):3193-7.

43.

Vascular endothelial growth factor and social support in patients with ovarian carcinoma.

Lutgendorf SK, Johnsen EL, Cooper B, Anderson B, Sorosky JI, Buller RE, Sood AK.

Cancer. 2002 Aug 15;95(4):808-15.

44.

Preoperative CA 125 levels: an independent prognostic factor for epithelial ovarian cancer.

Cooper BC, Sood AK, Davis CS, Ritchie JM, Sorosky JI, Anderson B, Buller RE.

Obstet Gynecol. 2002 Jul;100(1):59-64.

PMID:
12100804
45.

Quality of life and mood in women with gynecologic cancer: a one year prospective study.

Lutgendorf SK, Anderson B, Ullrich P, Johnsen EL, Buller RE, Sood AK, Sorosky JI, Ritchie J.

Cancer. 2002 Jan 1;94(1):131-40.

46.

Two successful pregnancies after conservative treatment of endometrial cancer and assisted reproduction.

Lowe MP, Bender D, Sood AK, Davis W, Syrop CH, Sorosky JI.

Fertil Steril. 2002 Jan;77(1):188-9.

PMID:
11779615
47.

Method and timing of tumor volume measurement for outcome prediction in cervical cancer using magnetic resonance imaging.

Mayr NA, Taoka T, Yuh WT, Denning LM, Zhen WK, Paulino AC, Gaston RC, Sorosky JI, Meeks SL, Walker JL, Mannel RS, Buatti JM.

Int J Radiat Oncol Biol Phys. 2002 Jan 1;52(1):14-22.

PMID:
11777618
48.

Paclitaxel and platinum chemotherapy for ovarian carcinoma during pregnancy.

Sood AK, Shahin MS, Sorosky JI.

Gynecol Oncol. 2001 Dec;83(3):599-600.

PMID:
11733979
49.

Papillary serous carcinoma of the uterus: increased risk of subsequent or concurrent development of breast carcinoma.

Geisler JP, Sorosky JI, Duong HL, Buekers TE, Geisler MJ, Sood AK, Anderson B, Buller RE.

Gynecol Oncol. 2001 Dec;83(3):501-3.

PMID:
11733962
50.

The p53 mutational spectrum associated with BRCA1 mutant ovarian cancer.

Buller RE, Lallas TA, Shahin MS, Sood AK, Hatterman-Zogg M, Anderson B, Sorosky JI, Kirby PA.

Clin Cancer Res. 2001 Apr;7(4):831-8.

Supplemental Content

Loading ...
Support Center